Denis Drygin - 01 Mar 2022 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Signature
Christopher Aker, Attorney in Fact
Issuer symbol
RGLS
Transactions as of
01 Mar 2022
Net transactions value
+$17,638
Form type
4
Filing time
01 Mar 2022, 16:58:56 UTC
Previous filing
07 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Purchase $17,638 +76,686 +329% $0.2300 100,000 01 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.